These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 187758)

  • 1. Various degrees of susceptibility of different stocks of rats to N-2-fluorenyldiacetamide hepatic carcinogenesis.
    Reuber MD
    J Natl Cancer Inst; 1976 Jul; 57(1):111-4. PubMed ID: 187758
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of age and sex on carcinoma and cirrhosis of the liver in AXC strain rats ingesting 0.025% N-2-fluorenyldiacetamide.
    Reuber MD
    Pathol Microbiol (Basel); 1975; 43(1):31-7. PubMed ID: 179045
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Carcinoma and cirrhosis of the liver in A X C male rats with one kidney ingesting 0.025% N-2-fluorenyldiacetamide.
    Reuber MD
    Pathol Microbiol (Basel); 1975; 42(2):119-26. PubMed ID: 1178230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of age and testosterone on the induction of hyperplastic nodules, carcinomas, and cirrhosis of the liver in rats ingesting n-2-fluorenyldiacetamide.
    Reuber MD
    Eur J Cancer (1965); 1976 Feb; 12(2):137-41. PubMed ID: 1261571
    [No Abstract]   [Full Text] [Related]  

  • 5. Varying degrees of susceptibility of inbred strains of rats to N-2-fluorenyldiacetamide hepatic carcinogenesis.
    Reuber MD
    Toxicol Appl Pharmacol; 1976 Sep; 37(3):525-30. PubMed ID: 973225
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of alpha-benzene hexachloride on 2-fluorenylacetamide carcinogenesis in rats.
    Hiasa Y; Ohshima M; Ohmori T; Murata Y
    Gan; 1978 Jun; 69(3):423-6. PubMed ID: 78868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of N-2-fluorenyldiacetamide induced hepatic carcinogenesis in rats by chloramphenicol: a dose-related phenomenon with reduced protein binding of carcinogen.
    Oster WF; Firminger HI; Morrison DM
    Yale J Biol Med; 1971; 43(4-5):297-306. PubMed ID: 4325376
    [No Abstract]   [Full Text] [Related]  

  • 8. Enhancement of 2-acetylaminofluorene liver carcinogenesis in rats fed a choline-devoid diet.
    Lombardi B; Shinozuka H
    Int J Cancer; 1979 Apr; 23(4):565-70. PubMed ID: 220201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MORPHOLOGIC AND BIOLOGIC CORRELATION OF LESIONS OBTAINED IN HEPATIC CARCINOGENESIS IN A X C RATS GIVEN 0.025 PERCENT N-2-FLUORENYLDIACETAMIDE.
    REUBER MD; FIRMINGER HI
    J Natl Cancer Inst; 1963 Dec; 31():1407-29. PubMed ID: 14087658
    [No Abstract]   [Full Text] [Related]  

  • 10. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. I. Ganglioside alterations in liver tumorigenesis and normal development.
    Merritt WD; Richardson CL; Keenan TW; Morré DJ
    J Natl Cancer Inst; 1978 Jun; 60(6):1313-27. PubMed ID: 206706
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular analysis of liver carcinogenesis. 3. Comparison of the ultrastructure of hyperplastic liver nodules and hepatocellular carcinomas induced in rat liver by 2-fluorenylacetamide.
    Merkow LP; Epstein SM; Farber E; Pardo M; Bartus B
    J Natl Cancer Inst; 1969 Jul; 43(1):33-63. PubMed ID: 4307705
    [No Abstract]   [Full Text] [Related]  

  • 12. The influence of postnecrotic cirrhosis on aflatoxin carcinogenesis in rats.
    Sun SC; Wei RD; Schaeffer BT
    Lab Invest; 1971 May; 24(5):368-72. PubMed ID: 4326522
    [No Abstract]   [Full Text] [Related]  

  • 13. Importance of testes in induction of hyperplastic nodules, carcinomas, and cirrhosis of liver in A times C male rats ingesting 0.025 percent N-2-fluorenyldiacetamide.
    Reuber MD
    J Natl Cancer Inst; 1974 Sep; 53(3):883-6. PubMed ID: 4370092
    [No Abstract]   [Full Text] [Related]  

  • 14. Increased susceptibility to carcinoma of the liver in rats with one kidney ingesting N-4-(4'-fluorobiphenyl) acetamide.
    Reuber MD
    Gan; 1976 Apr; 67(2):307-11. PubMed ID: 184008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of growth hormone on hepatic carcinogenesis and cirrhosis in AxC rats given N-2 fluorenyldiacetamide.
    Reuber MD
    Cancer Res; 1968 Nov; 28(11):2177-9. PubMed ID: 5723960
    [No Abstract]   [Full Text] [Related]  

  • 16. Gangliosides of liver tumors induced by N-2-fluorenylacetamide. II. Alterations in biosynthetic enzymes.
    Merritt WD; Morré DJ; Keenan TW
    J Natl Cancer Inst; 1978 Jun; 60(6):1329-37. PubMed ID: 206707
    [No Abstract]   [Full Text] [Related]  

  • 17. The cellular analysis of liver carcinogenesis. V. Ultrastructural alterations within hepatocellular carcinoma induced by ethionine.
    Merkow LP; Epstein SM; Slifkin M; Farber E; Pardo M
    Lab Invest; 1972 Mar; 26(3):300-5. PubMed ID: 4335732
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of hormones on N-2-fluorenyldiacetamide-induced hyperplastic hepatic nodules in rats.
    Reuber MD
    J Natl Cancer Inst; 1969 Aug; 43(2):445-52. PubMed ID: 4307866
    [No Abstract]   [Full Text] [Related]  

  • 19. Hepatic carcinogenesis in thyroidectomized rats: apparent blockade at the stage of initiation.
    Goodall CM
    Cancer Res; 1966 Sep; 26(9):1880-3. PubMed ID: 4288670
    [No Abstract]   [Full Text] [Related]  

  • 20. Effect of diethylnitrosamine on the livers of rats after high oral doses administered at intervals varying between three and twenty-four days.
    Steinhoff D
    Acta Hepatogastroenterol (Stuttg); 1975 Apr; 22(2):72-7. PubMed ID: 165650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.